Clémence Boutière

Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin‐4 Antibody Diseases

Pierre Durozard, Audrey Rico, Clémence Boutière et al. · Annals of Neurology · 2019 · 154 citations

Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?

Adil Maarouf, Audrey Rico, Clémence Boutière et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 72 citations · Full text

Improvement of spasticity following intermittent theta burst stimulation in multiple sclerosis is associated with modulation of resting-state functional connectivity of the primary motor cortices

Clémence Boutière, Caroline Rey, Wafaa Zaaraoui et al. · Multiple Sclerosis Journal · 2016 · 62 citations

Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases

Alexandre Avouac, Adil Maarouf, Jan‐Patrick Stellmann et al. · Neurology Neuroimmunology & Neuroinflammation · 2021 · 38 citations · Full text

Efficacy of rituximab in refractory RRMS

Pierre Durozard, Adil Maarouf, Clémence Boutière et al. · Multiple Sclerosis Journal · 2018 · 36 citations